Mineralys Therapeutics, Inc. (MLYS) Q1 2025 Earnings
MLYS·Reported May 12, 2025·After market close
Diluted EPS came in at $-0.79 (-12.9% YoY), beat the $-1.02 consensus by $0.23.
Diluted EPS
$-0.79beat by $0.23
Consensus: $-1.02
Financial Snapshot
Trailing eight quarters through Q1 2025
Q1 2025 Earnings FAQ
Common questions about Mineralys Therapeutics, Inc.'s Q1 2025 earnings report.
Mineralys Therapeutics, Inc. (MLYS) reported Q1 2025 earnings on May 12, 2025 after market close.
Mineralys Therapeutics, Inc. reported diluted EPS of $-0.79 for Q1 2025.
EPS beat the consensus estimate of $-1.02 by $0.23.
Compared to the same quarter a year prior, diluted EPS declined 12.9% from $-0.70.
You can read the 10-Q periodic report (0001933414-25-000058) directly on SEC EDGAR. The filing index links above go to sec.gov.